Difference between revisions of "Team:XJTLU-CHINA/Safety"
Kerberos01 (Talk | contribs) |
|||
(7 intermediate revisions by 3 users not shown) | |||
Line 173: | Line 173: | ||
width: 100%; | width: 100%; | ||
position: relative; | position: relative; | ||
− | background-color: | + | background-color: black; |
} | } | ||
Line 312: | Line 312: | ||
font-weight: 600; | font-weight: 600; | ||
padding-top: 111px; | padding-top: 111px; | ||
+ | padding-left:10px; | ||
} | } | ||
Line 318: | Line 319: | ||
font-weight: 600; | font-weight: 600; | ||
padding-top: 5px; | padding-top: 5px; | ||
+ | padding-left:10px; | ||
} | } | ||
+ | |||
.navilogo{ | .navilogo{ | ||
Line 652: | Line 655: | ||
<li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li> | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J1">Map description</a></li> | ||
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li> | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li> | ||
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4"> | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">The second trial of RNAT testing</a></li> |
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description# | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J5">Chromo-protein testing</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 752: | Line 755: | ||
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li> | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J2">RNAT</a></li> | ||
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Improve experiment of RNAT</a></li> | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J4">Improve experiment of RNAT</a></li> | ||
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description# | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Description#J5">Chromo-protein testing</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 817: | Line 820: | ||
<li class="ZmainNavi col1"> | <li class="ZmainNavi col1"> | ||
<div id="ZPrimaryNaviBg9"> | <div id="ZPrimaryNaviBg9"> | ||
− | <a class="ZprimaryNavi" href="https://2015.igem.org/Team:XJTLU-CHINA/ | + | <a class="ZprimaryNavi" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations">Collaboration</a> |
</div> | </div> | ||
<ul> | <ul> | ||
− | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/ | + | <li><a class="jump1" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J1">with NYU-Shanghai</a></li> |
<li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#synbio">Synbio-tech</a></li> | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#synbio">Synbio-tech</a></li> | ||
− | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/ | + | <li><a class="jump2" href="https://2015.igem.org/Team:XJTLU-CHINA/Collaborations#J2">with BIT-China</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 846: | Line 849: | ||
</div> | </div> | ||
<div class="subNavi"> | <div class="subNavi"> | ||
− | <p>Biosafety is probably the most controversial issue in synthetic biology. Being responsible to everyone, 2015 XJTLU team took variety of measurements to promote the safety in the lab. We reached an agreement and drafted a lab policy. We used low hazard strains to | + | <p>Biosafety is probably the most controversial issue in synthetic biology. Being responsible to everyone, 2015 XJTLU team took variety of measurements to promote the safety in the lab. We reached an agreement and drafted a lab policy. We used low hazard strains to minimize the potential risks of our project.</p> |
</div> | </div> | ||
</div> | </div> | ||
Line 894: | Line 897: | ||
<div class="lv2" > | <div class="lv2" > | ||
<h3>Researcher Safety</h3> | <h3>Researcher Safety</h3> | ||
− | <div class="lv2-1"><i>Escherichia coli< | + | <div class="lv2-1"><i>Escherichia coli</i>, as an engineering bacterium, is the cell line that we normally work with. As an engineering bacterium, it has been documented as a non-hazard microbe and extensively used for decades. The carcinogenic experiment reagents, such as Ethidium bromide the DNA dye, had been replaced by less harmful reagents before initiating the project. Moreover, we followed the rules and firmly believe that the safety is always priority to our project.</div> |
<br/> | <br/> | ||
<h3>Public Safety</h3> | <h3>Public Safety</h3> | ||
Line 918: | Line 921: | ||
<h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h2> | <h2>Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues?</h2> | ||
<div class="lv2" > | <div class="lv2" > | ||
− | <div class="lv2-1">No. we did not use any new BioBrick parts. All BioBrick parts were derived from the previous iGEM team or the literature and which all had been expressed in E. coli previously and no hazardous conclusion was drawn. The only difference is that integrating various protein genes into one construction forms a relatively complicated bacteria internal environment, which is inclined to weaken the cells.</div> | + | <div class="lv2-1">No. we did not use any new BioBrick parts. All BioBrick parts were derived from the previous iGEM team or the literature and which all had been expressed in <i>E. coli</i> previously and no hazardous conclusion was drawn. The only difference is that integrating various protein genes into one construction forms a relatively complicated bacteria internal environment, which is inclined to weaken the cells.</div> |
</div> | </div> | ||
</div> | </div> | ||
Line 972: | Line 975: | ||
<div class="footer"> | <div class="footer"> | ||
<div class="footerBg"> | <div class="footerBg"> | ||
− | <div class="container" style="text-align: center"> | + | <div class="container" style="text-align: center; padding-top: 40px;"> |
<img class="logo" src="https://static.igem.org/mediawiki/2015/d/da/LogoXJTLU15.png" height="53"> | <img class="logo" src="https://static.igem.org/mediawiki/2015/d/da/LogoXJTLU15.png" height="53"> | ||
<img class="logo" src="https://static.igem.org/mediawiki/2015/9/96/Logo2XJTLU15.png" height="50"> | <img class="logo" src="https://static.igem.org/mediawiki/2015/9/96/Logo2XJTLU15.png" height="50"> | ||
− | <img class="logo" src="https://static.igem.org/mediawiki/2015/e/e3/%E6%B3%93%E8%BF%85%E7%A7%91%E6%8A%80Synbio_Technologies_Logo.png" height="50"> | + | <img class="logo" src="https://static.igem.org/mediawiki/2015/e/e3/%E6%B3%93%E8%BF%85%E7%A7%91%E6%8A%80Synbio_Technologies_Logo.png" height="50" > |
<br/> | <br/> | ||
<img class="logo" src="https://static.igem.org/mediawiki/2015/4/41/AgilentXJTLU15.png" height="50" style="margin-top:60px;"> | <img class="logo" src="https://static.igem.org/mediawiki/2015/4/41/AgilentXJTLU15.png" height="50" style="margin-top:60px;"> |
Latest revision as of 16:16, 4 October 2015
XJTLU-CHINA
Saftey
Biosafety is probably the most controversial issue in synthetic biology. Being responsible to everyone, 2015 XJTLU team took variety of measurements to promote the safety in the lab. We reached an agreement and drafted a lab policy. We used low hazard strains to minimize the potential risks of our project.
Policy
(Sorry for only Chinese version.)
The policy not only includes the main clauses in safety guideline of laboratory but also add a few special requirements as well as some tips. For instance, “having a good mood” is documented as the top one because keeping your mind clean, clear, positive and free is usually a good way to ensure the correctness and safety of experiments. In order to guarantee the implementation of the policy, we chose one of our team members as a supervisor.